|
The Pharmaceutical Price Regulation Scheme (PPRS) is the mechanism used by the UK Department of Health to ensure that the NHS has access to good quality branded medicines at reasonable prices. It involves a non-contractual agreement between the UK Department of Health and The Association of the British Pharmaceutical Industry (ABPI). The scheme applies to all branded, licensed medicines available on the NHS. The purpose of the scheme is to achieve a balance between reasonable prices for the NHS and a fair return for the pharmaceutical industry. The current PPRS scheme, using a value-based pricing mechanism, came into effect on 1 January 2014, to run for no less than 5 years.〔Department of Health (The Pharmaceutical Price Regulation Scheme 2014 )〕 It replaced an earlier scheme running from 2009 to 2013.〔Department of Health (The Pharmaceutical Price Regulation Scheme 2009 )〕 In December 2014 Hoffmann-La Roche successfully appealed against a decision of the National Institute for Health and Care Excellence appraisal committee in respect of Kadcyla on the basis that it should have considered the fact that under the Scheme, the industry had agreed to cap growth in the drugs bill to 0-1.9% a year for the next five years. Roche said this had “fundamentally changed” the nature of how NICE should consider cost effectiveness. ==Purpose and objectives== As the primary buyer of medicines in the UK, the Department of Health has an interest in ensuring medicines are available at reasonable prices. However it is also important that pharmaceutical companies, represented by the ABPI, are able to maintain sufficient levels of profit and competitiveness to enable them to invest in sustained research and development. The 2009 PPRS agreement outlines its primary objectives as to: # Deliver value for money # Encourage innovation # Promote access and uptake for new medicines # Provide stability, sustainability and predictability 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Pharmaceutical Price Regulation Scheme」の詳細全文を読む スポンサード リンク
|